DrugPatentWatch Database Preview
Investigational Drug Information for Bococizumab
Email this page to a colleague
What is the drug development status for Bococizumab?
Bococizumab is an investigational drug.
There have been 10 clinical trials for Bococizumab.
The most recent clinical trial was a Phase 3 trial, which was initiated on October 29th 2013.
The most common disease conditions in clinical trials are Hyperlipoproteinemias, Hyperlipidemias, and Dyslipidemias. The leading clinical trial sponsors are Pfizer, San Francisco General Hospital, and University of California, San Francisco.
There are seven US patents protecting this investigational drug and sixty-nine international patents.
Summary for Bococizumab
| US Patents | 7 |
| International Patents | 69 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2013-10-29) |
| Vendors | 0 |
Recent Clinical Trials for Bococizumab
| Title | Sponsor | Phase |
|---|---|---|
| Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects | Pfizer | Phase 3 |
| Bococizumab HIV Evaluation (B-HIVE) Study | Pfizer | Phase 3 |
| Bococizumab HIV Evaluation (B-HIVE) Study | San Francisco General Hospital | Phase 3 |
Clinical Trial Summary for Bococizumab
Top disease conditions for Bococizumab
Top clinical trial sponsors for Bococizumab
US Patents for Bococizumab
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Bococizumab | ⤷ Try it Free | Peptide-mediated delivery of immunoglobulins across the blood-brain barrier | Mayo Foundation for Medical Education and Research (Rochester, MN) | ⤷ Try it Free |
| Bococizumab | ⤷ Try it Free | Antigen-binding proteins that activate the leptin receptor | REGENERON PHARMACEUTICALS, INC. (Tarrytown, NY) | ⤷ Try it Free |
| Bococizumab | ⤷ Try it Free | Cholestosome vesicles for incorporation of molecules into chylomicrons | THERASYN SENSORS, INC. (Eggertsville, NY) | ⤷ Try it Free |
| Bococizumab | ⤷ Try it Free | Treatment with anti-PCSK9 antibodies | Pfizer Inc. (New York, NY) | ⤷ Try it Free |
| Bococizumab | ⤷ Try it Free | Binding-triggered transcriptional switches and methods of use thereof | The Regents of the University of California (Oakland, CA) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Bococizumab
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Bococizumab | Argentina | AR106319 | 2035-10-12 | ⤷ Try it Free |
| Bococizumab | Argentina | AR115992 | 2035-10-12 | ⤷ Try it Free |
| Bococizumab | Australia | AU2016338851 | 2035-10-12 | ⤷ Try it Free |
| Bococizumab | Brazil | BR112018007318 | 2035-10-12 | ⤷ Try it Free |
| Bococizumab | Canada | CA3000215 | 2035-10-12 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
